overdose prevention

Episode 20: The Pitfalls of Mainstream Harm Reduction

via Troy Farah

In this episode, Chris and Zach sit down with Eliza Wheeler of the Harm Reduction Coalition in San Francisco. Wheeler has been working in harm reduction, distributing syringes and naloxone directly to people who use drugs, for over two decades. She’s seen a lot of progress in her lifetime. But as harm reduction goes mainstream, Wheeler sees how easily the bedrock values and principles of the movement can be compromised and coopted by political forces. Zach, Chris, and Eliza talk about how funds for naloxone get in the wrong hands, how syringe exchanges deal with NIMBYism, and how the heart of her harm reduction philosophy is bodily autonomy.

Follow Narcotica on FacebookTwitter and support us on Patreon. Your support is appreciated!

Follow the DOPE Project ‏and the Harm Reduction Coalition on Twitter.

Producers: Christopher Moraff, Troy Farah, Zachary Siegel
Co-Producer: Aaron Ferguson
Music: Glass Boy and Aaron Ferguson
Image Credit: Chris Moraff / Edit by Troy Farah

Episode 19: Debunking Bupe Diversion Myths

If you ask many, many people whose lives have been upended by opioids, buprenorphine is a life saver. It can literally cut the risk of a fatal overdose by half or more in folks who have an opioid addiction. Also known as Subutex or Suboxone, buprenorphine is one of the three FDA approved medications to treat what’s formally known as opioid use disorder. It’s a partial agonist at opioid receptors, relieving cravings but with far less risk for overdose than other opioids like heroin, which are full agonists.

Zachary Siegel, Troy Farah and Christopher Moraff speak with Molly Doernberg, a grad student at Yale School of Public Health, who co-authored a recent paper called “Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?” which was published in the journal Substance Abuse last April. They discuss what buprenorphine is, why people take it, and why stigma and fears that buprenorphine may be used illicitly are actually contributing to more overdose deaths.



Follow Narcotica on FacebookTwitter and support us on Patreon. Your support is appreciated!

Read Doernberg’s paper here: https://doi.org/10.1080/08897077.2019.1572052 and follow her on Twitter.

Producers: Christopher Moraff, Troy Farah, Zachary Siegel
Co-Producer: Aaron Ferguson
Music: Glass Boy and Aaron Ferguson
Image Credit: Chris Moraff / Edit by Troy Farah

Episode 4: Supervised Consumption Breaks Rod Rosenstein’s Brain


In response to Deputy Attorney General Rod Rosenstein’s outrageous supervised consumption op-ed in the New York Times, the Narcotica team speaks with Laura Thomas, of the Drug Policy Alliance, who broke down the obstacles harm reduction workers face in opening a site in the United States. Thomas, who is deputy state director at DPA, has been championing supervised consumption sites for over a decade, because she knows what the data says: SCS save lives.

But how long until we see a facility in the U.S.? We discuss the status of many projects in Washington, New York, and California, and what kind of fight we can expect from the Department of Justice.

You can follow Laura on Twitter @LThomas and learn more about the Drug Policy Alliance at drugpolicy.org.

Follow Narcotica on Facebook, Twitter and support us on Patreon.

Photo credit: Composite by Troy Farah